BioNTech surges 3% while Opendoor jumps 103% - here's what investors missed
Key Points
- The CDC panel's decision to allow Covid vaccines without pre...
The CDC advisory panel just handed BioNTech a gift wrapped in regulatory tape, and investors responded like kids on Christmas morning. By voting against requiring doctor's prescriptions for Covid vaccines including BioNTech's Comirnaty, the panel essentially said "let the people have their shots without jumping through medical hoops." Sure, they can't actually enforce anything - that's the FDA's job - but their recommendations carry more weight than a sumo wrestler's opinion on portion sizes.
BioNTech (BNTX) shares climbed nearly 3% on September 22, leaving the S&P 500's measly 0.4% gain look...
While we have taken every measure to build an AI pipeline that generates credible and accuracte news, we still encourage you to conduct your own research before making investment decisions. InsAIght's content should not be considered professional financial or trading advice.